Skip to main content

Scott Soefje, PharmD, MBA, BCOP, FCCP

Director, Pharmacy Cancer Care of Mayo Clinic
Rochester, MN
Austin, TX

Scott Soefje, PharmD, MBA, BCOP, FCCP
Director, Pharmacy Cancer Care
Mayo Clinic
Rochester, MN

Authored Items

505(b)(2) Drugs: New Chaos for Infusion Centers
By Scott Soefje, PharmD, MBA, BCOP, FCCP
October 2025 Vol 18, No 4
Financial/Insurance Information
Originally intended to foster innovation, such as extended-release formulations or novel delivery systems, recent years have seen a surge in 505(b)(2) applications for minor changes, such as vial size. Read More ›